Morphochemical changes in brain structures in the course of chronic haloperidol treatment and the correction of these changes with tuftsin

Molecular and Chemical Neuropathology

Volumn 30, Issue 3, 1997, Pages 213-222

  Gershtein, L M ^a   Dobrynina, M T ^a   Sergutina, A V ^a  

^a BRAIN RESEARCH INSTITUTE   (Russian Federation)

Author keywords

aminopeptidase; caudate nucleus; haloperidol; interferometry; protein metabolism; Sensorimotor cortex; tuftsin

Indexed keywords

AMINOPEPTIDASE; HALOPERIDOL; TUFTSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRADYKINESIA; BRAIN; CAUDATE NUCLEUS; CELL NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN METABOLISM; RAT; SENSORIMOTOR CORTEX;

EID: 0030912251     PISSN: 10447393     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02815099     Document Type: Article

References (20)

1. Adrianov O. S., Molodkina L. N., and Yamshchikova N. G. (1987) Association systems of the brain and extrapolation behavior. USSR Academy of Medical Sciences, Moscow, Medicine, p. 192.
2. Andreev S. M., Vanohin K. V., Antonova L. V., and Ashmarin I. P. (1980) Tetrapeptid tuftsin influence to the emotional behaviour of animals. DAS USSR 253,2, 498-500.
3. Colls A. R. (1984) Basal ganglia and Parkinson's disease: neurobiological and pharmacological aspects in animals and man. Clin. Neurol. Neurosurg. 86,3, 178-195.
4. Dovedova Ye. L. and Popova N. S. (1993) Pathogenetic mechanisms of drug parkinsonism: biochemical and bioelectric evaluation of haloperidol effects in experiment. S.S. Korsakov J. Neurol. Psychiatry 93,6, 15-18.
5. Fridkin M. and Gottlieb P. (1981) Tuftsin, Thr-Lys-Pro-Agr. Mol. Cell. Biochem. 41, 73-97.
6. Funk K. F., Schmidt Z., and Westerman K. H. (1986) Zur Frage der biochemischen Charakterisierung und Differenzierung der dophaminergen Supersensititat bei der Ratte. Biomed. Biochim. Acta 45,3, 393-399.
7. Gershtein L. M. (1965) Histochemical method for the determination of amino-peptidase in the nervous tissue. J. Cytol. 6, 769-773.
8. Gershtein L. M., Dovedova E. L., Kamysheva A. C., Sergutina A. V., and Chebotareva T. L. (1990) Effect of tuftsin on some patterns of metabolism in animal brain locomotory system. Voprosi Med. Chim. 4, 15-17.
9. Kamensky A. A., Kalikhevich V. N., and Sarycheva N. Yu. (1986) Time course of behavioral tuftsin effect. Bull. Exp. Biol. Med. 101,1, 55-57.
10. Kazakova P. V. and Nezlina N. I. (1972) Changes in evoked potentials and neuronal dry mass of cat motor cortex neurons in the process of compensatory reorganization. J. Neurophysiol. 4,1, 41-47.
11. Konkoy C. S., Oakes M. G., and Davis T. P. (1993) Chronic treatment with neuroleptics alters neutral endopeptidase 24.11 activity in rat brain regions. Peptides 14, 1017-1020.
12. Matz V. N., Segal O. L., and Kruglikov R. I. (1987) Change in the dry weight of neurons of motor cortex in rats at unlocal alimentary instrumental reflex elaboration in normal conditions and at the background of iproniasid action. Proc. USSR Acad. Sci. Ser. Biol. 3, 430-437.
13. Mettler F. A. and Crandall A. (1959) Relation between parkinsonism and psychiatric disorder. J. Nervous Mental Dis. 129,1, 551-559.
14. Najjar V. A. and Nishioka K. (1970) Tuftsin, a physiological phagocytosis - stimulating peptide. Nature 228, 672,673.
15. Nishioka K., Constantopoulus A., Saton P. S., Mitchell W., and Najjar V. A. (1973) Characteristics and isolation of the phagocytosis - stimulating peptide, tuftsin. Biochim. Biophys. Acta 310, 217-229.
16. Nishioka K., Babcock G. E., Phillips J. N., and Noyes R. D. (1981) Anti-tumor effect of tuftsin. Mol. Cell. Biochem. 41, 13-18.
17. Pehek E. A. and Yamamoto B. K. (1994) Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. J. Neurochem. 63, 2118-2124.
18. Popova N. S. and Kachalova L. M. (1991) Principles of intercentral interaction variants of disturbances and ways of reconstruction. Jurnal vyschei nervnoi deyatelnosty. J. Higher Nervous Activity 41,1, 9-32.
19. Valdman A. V. (1981) Neuropeptides and emotional behaviour. Adv. Pharmacol. Ther. Por. Int. Congr. 8th (Pub. 1982), 1, 165-173.
20. Yoshida Y., Ono T., Kowano K., and Miyagishi T. (1994) Distinct sites of dopaminergic and glutamatergic regulation of haloperidol-induced catalepsy within the rat caudate-putamen. Brain Res. 639, 139-148.